MRC1 and metastatic malignant neoplasm: To date, the efficacy of chemotherapy for advanced/metastatic cancer in individuals with LS or MSI-H has not yet been clarified, but the efficacy of PD-1 inhibition in metastatic deficient MMR protein staining or MSI-H solid tumors has been demonstrated (30–32).